103 related articles for article (PubMed ID: 38724414)
1. miRNA Biology in Chronic Lymphocytic Leukemia.
Bayraktar R; Fontana B; Calin GA; Nemeth K
Semin Hematol; 2024 Mar; ():. PubMed ID: 38724414
[TBL] [Abstract][Full Text] [Related]
2. RNA Editing Alters miRNA Function in Chronic Lymphocytic Leukemia.
Gassner FJ; Zaborsky N; Feldbacher D; Greil R; Geisberger R
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32380696
[TBL] [Abstract][Full Text] [Related]
3. Role of microRNAs in regulation of the TNF/TNFR gene superfamily in chronic lymphocytic leukemia.
Srivastava S; Tsongalis GJ; Kaur P
Clin Biochem; 2016 Nov; 49(16-17):1307-1310. PubMed ID: 27544753
[TBL] [Abstract][Full Text] [Related]
4. Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model.
Zhang X; Han Y; Hu X; Wang H; Tian Z; Zhang Y; Wang X
Biomark Res; 2022 Oct; 10(1):75. PubMed ID: 36271413
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia.
Katsaraki K; Karousi P; Artemaki PI; Scorilas A; Pappa V; Kontos CK; Papageorgiou SG
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546241
[TBL] [Abstract][Full Text] [Related]
6. microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.
Negrini M; Cutrona G; Bassi C; Fabris S; Zagatti B; Colombo M; Ferracin M; D'Abundo L; Saccenti E; Matis S; Lionetti M; Agnelli L; Gentile M; Recchia AG; Bossio S; Reverberi D; Rigolin G; Calin GA; Sabbioni S; Russo G; Tassone P; Morabito F; Ferrarini M; Neri A
Clin Cancer Res; 2014 Aug; 20(15):4141-53. PubMed ID: 24916701
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
Wang LQ; Chim CS
Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
[TBL] [Abstract][Full Text] [Related]
8. Serum Expression of Seven MicroRNAs in Chronic Lymphocytic Leukemia Patients.
Farzadfard E; Kalantari T; Tamaddon G
J Blood Med; 2020; 11():97-102. PubMed ID: 32210655
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemia.
Ali A; Mahla SB; Reza V; Hossein A; Bahareh K; Mohammad H; Fatemeh S; Mostafa AB; Leili R
EJHaem; 2024 Feb; 5(1):191-205. PubMed ID: 38406506
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
[TBL] [Abstract][Full Text] [Related]
11. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?
Van Roosbroeck K; Calin GA
Semin Oncol; 2016 Apr; 43(2):209-14. PubMed ID: 27040698
[TBL] [Abstract][Full Text] [Related]
14. miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance- An emphasis on the interaction of signaling pathways.
Doghish AS; Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Fathi D; Elsakka EGE
Pathol Res Pract; 2023 Mar; 243():154363. PubMed ID: 36764011
[TBL] [Abstract][Full Text] [Related]
15. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
16. B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia.
Schmid VK; Khadour A; Ahmed N; Brandl C; Nitschke L; Rajewsky K; Jumaa H; Hobeika E
Haematologica; 2022 Aug; 107(8):1796-1814. PubMed ID: 35021605
[TBL] [Abstract][Full Text] [Related]
17. Non-Coding RNAs: The "Dark Side Matter" of the CLL Universe.
Lingua MF; Carrà G; Maffeo B; Morotti A
Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33669945
[TBL] [Abstract][Full Text] [Related]
18. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
[TBL] [Abstract][Full Text] [Related]
19. Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs.
Patz M; Pallasch CP; Wendtner CM
Leuk Lymphoma; 2010 Aug; 51(8):1379-81. PubMed ID: 20687796
[TBL] [Abstract][Full Text] [Related]
20. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis.
Marton S; Garcia MR; Robello C; Persson H; Trajtenberg F; Pritsch O; Rovira C; Naya H; Dighiero G; Cayota A
Leukemia; 2008 Feb; 22(2):330-8. PubMed ID: 17989717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
